SCHEMBL3218102

SCHEMBL3218102

Cc1cccc(C)c1-c1cccc2c1O[C@H](CN)CN2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAB2 O43741 2/20 0.34
PRKAG1 P54619 2/20 0.34
PRKAA2 P54646 2/20 0.34
PRKAA1 Q13131 2/20 0.34
PRKAG3 Q9UGI9 2/20 0.34
PRKAG2 Q9UGJ0 2/20 0.34
PRKAB1 Q9Y478 2/20 0.34
BRD4 O60885 3/20 0.34
CREBBP Q92793 3/20 0.34
CASR P41180 1/20 0.34
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 2/20 0.33
PKM P14618 1/20 0.33
HTR1A P08908 2/20 0.31
TYMS P04818 1/20 0.31
MYC P01106 1/20 0.30
HPGD P15428 1/20 0.30
NOS2 P35228 1/20 0.30
HTR7 P34969 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3218165 1.00 PRKAB2 (0.34) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3213753 1.00 PRKAB2 (0.34) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3203168 0.91 HTR2C (0.36) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3209728 0.91 HTR2C (0.36) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3208813 0.91 HTR2C (0.36) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3222181 0.90 PKM (0.35) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3211615 0.90 PKM (0.35) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3216852 0.90 PKM (0.35) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3196377 0.90 BRD4 (0.33) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3197309 0.90 BRD4 (0.33) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035871-A1 BENZOXAZINE DERIVATIVES AND USES THEREOF WYETH 2010-02-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035871-A1 BENZOXAZINE DERIVATIVES AND USES THEREOF HTR2C, HTR5A, NPY1R PRKAB2 2961/4885PRKAG1 2626/4885PRKAA2 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.